Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec;148(6):1517-1527.
doi: 10.1378/chest.15-0458.

Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New Insights

Affiliations
Review

Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New Insights

Pamela J McShane et al. Chest. 2015 Dec.

Abstract

Since pulmonary nontuberculous mycobacteria (PNTM) lung disease was last reviewed in CHEST in 2008, new information has emerged spanning multiple domains, including epidemiology, transmission and pathogenesis, clinical presentation, diagnosis, and treatment. The overall prevalence of PNTM is increasing, and in the United States, areas of highest prevalence are clustered in distinct geographic locations with common environmental and socioeconomic factors. Although the accepted paradigm for transmission continues to be inhalation from the environment, provocative reports suggest that person-to-person transmission may occur. A panoply of host factors have been investigated in an effort to elucidate why infection from this bacteria develops in ostensibly immunocompetent patients, and there has been clarification that immunocompetent patients exhibit different histopathology from immunocompromised patients with nontuberculous mycobacteria infection. It is now evident that Mycobacterium abscessus, an increasingly prevalent cause of PNTM lung disease, can be classified into three separate subspecies with differing genetic susceptibility or resistance to macrolides. Recent publications also raise the possibility of improved control of PNTM through enhanced adherence to current treatment guidelines as well as new approaches to treatment and even prevention. These and other recent developments and insights that may inform our approach to PNTM lung disease are reviewed and discussed.

PubMed Disclaimer

Figures

Figure 1 –
Figure 1 –
Chest CT image of a 70-y-old woman with a tall, lean body habitus; mitral valve prolapse; and a single CFTR gene mutation (G551D). She has an intermediate sweat chloride test result and presented with a chronic debilitating cough. Sputum cultures were positive for Mycobacterium avium-intracellulare complex. The CT image demonstrates multiple nodules bilaterally with patchy bronchiectatic changes and tree-in-bud abnormalities (arrow).
Figure 2 –
Figure 2 –
Chest CT image of a 65-y-old woman who presented with productive cough, weight loss, and fatigue. Sputum was acid-fast bacilli smear positive and culture positive for Mycobacterium abscessus. This CT image shows a more advanced stage of bilateral nodular bronchiectasis than seen in the patient presented in Figure 1.
Figure 3 –
Figure 3 –
Chest CT coronal view image of an 81-y-old man with COPD, cough, and sputum showing a large right-side upper-lobe cavitary process with bilateral apical pleural thickening. Multiple sputum specimens were acid-fast bacilli smear negative, but cultures were positive for Mycobacterium avium-intracellulare complex.
Figure 4 –
Figure 4 –
Chest CT image of a 47-y-old woman with diffuse reticulonodular infiltrates bilaterally. The patient presented with acute onset of cough, dyspnea, and low-grade fever after swimming. A diagnosis of hypersensitivity pneumonitis was made, and etiology was traced to Mycobacterium avium exposure at the pool.

Comment in

References

    1. Glassroth J. Pulmonary disease due to nontuberculous mycobacteria. Chest. 2008;133(1):243-251. - PubMed
    1. Pitchenik AE. PPD-tuberculin and PPD-Battey dual skin testing of hospital employees and medical students. South Med J. 1978;71(8):917-918, 922. - PubMed
    1. Griffith DE, Aksamit T, Brown-Elliott BA, et al. ; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases [published correction appears in Am J Respir Crit Care Med. 2007;175(7):744-745]. Am J Respir Crit Care Med. 2007;175(4):367-416. - PubMed
    1. Prevots DR, Shaw PA, Strickland D, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182(7):970-976. - PMC - PubMed
    1. Billinger ME, Olivier KN, Viboud C, et al. Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis. 2009;15(10):1562-1569. - PMC - PubMed

MeSH terms

Substances